dc.contributor.author |
Kenealy, Timothy |
en |
dc.date.accessioned |
2014-12-10T03:55:03Z |
en |
dc.date.issued |
2007-01 |
en |
dc.identifier.citation |
Clinical Evidence, 2007, 10pp. |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/23755 |
en |
dc.description.abstract |
About 10-30% of people present to primary healthcare services with sore throat each year. The causative organisms of sore throat may be bacteria (most commonly Streptococcus) or viruses (typically rhinovirus), although it is difficult to distinguish bacterial from viral infections clinically.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to reduce symptoms of acute infective sore throat? What are the effects of interventions to prevent complications of acute infective sore throat? We searched: Medline, Embase, The Cochrane Library and other important databases up to May 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).We found eight systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.In this systematic review we present information relating to the effectiveness and safety of the following interventions: antibiotics, corticosteroids, non-steroidal anti-inflammatory drugs, paracetamol, and probiotics. |
en |
dc.format.medium |
Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
BMJ clinical evidence |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Streptococcus |
en |
dc.subject |
Streptococcal Infections |
en |
dc.subject |
Pharyngitis |
en |
dc.subject |
Acute Disease |
en |
dc.subject |
Acetaminophen |
en |
dc.subject |
Anti-Inflammatory Agents, Non-Steroidal |
en |
dc.subject |
Administration, Oral |
en |
dc.subject |
Incidence |
en |
dc.title |
Sore throat. |
en |
dc.type |
Journal Article |
en |
pubs.volume |
2007 |
en |
dc.rights.holder |
Copyright:
BMJ Publishing Group Limited |
en |
dc.identifier.pmid |
19450346 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
review-article |
en |
pubs.subtype |
Review |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
65406 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Medicine Department |
en |
dc.identifier.eissn |
1752-8526 |
en |
pubs.record-created-at-source-date |
2009-05-19 |
en |
pubs.dimensions-id |
19450346 |
en |